Forum Markets, Inc. (FRMM)
6.00
+0.52
(+9.49%)
USD |
NASDAQ |
Aug 24, 16:00
6.00
0.00 (0.00%)
After-Hours: 19:58
Forum Markets Debt to Equity Ratio : 0.203 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.203 |
| March 31, 2026 | 0.161 |
| December 31, 2025 | 0.2411 |
| September 30, 2025 | 1.228 |
| June 30, 2025 | 0.2625 |
| March 31, 2025 | 0.0197 |
| December 31, 2024 | 0.0001 |
| September 30, 2024 | 0.1295 |
| June 30, 2024 | -1.058 |
| March 31, 2024 | -0.8265 |
| December 31, 2023 | -10.34 |
| September 30, 2023 | -2.378 |
| June 30, 2023 | 0.0915 |
| March 31, 2023 | 0.122 |
| December 31, 2022 | 0.1181 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.0168 |
| June 30, 2022 | 0.0217 |
| March 31, 2022 | 0.0349 |
| December 31, 2021 | 0.0498 |
| September 30, 2021 | 0.0111 |
| June 30, 2021 | 0.5843 |
| March 31, 2021 | 0.0799 |
| September 30, 2020 | 0.7189 |
| June 30, 2020 | 0.3343 |
| March 31, 2020 | 0.5587 |
| December 31, 2019 | 0.5351 |
| September 30, 2019 | 0.0604 |
| June 30, 2019 | 0.0306 |
| March 31, 2019 | 0.0153 |
| December 31, 2018 | 0.0032 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abeona Therapeutics, Inc. | 0.1552 |
| Corcept Therapeutics, Inc. | 0.0133 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 159.03M |
| Total Liabilities (Quarterly) | 31.23M |
| Shareholders Equity (Quarterly) | 127.80M |
| Current Ratio | 2.688 |
| Net Debt Paydown Yield | -7.19% |